|
|
|
|
San Francisco November 4 - 8, 2011
Advance liver cancer vaccine now: Patients with advanced hepatocellular carcinoma (HCC) appeared to gain a survival benefit when treated with the higher of two doses of an investigational oncolytic virus, results of a small, phase II trial showed. Treatment with the higher dose More...
|
|
|
|
|